Search Results for "B.com Part II Results 2009 Private"

23:37 EDT 17th September 2014 | BioPortfolio

Matching Channels

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Lipitor

Lipitor was the best selling drug in 2009, with the 2009 annual sales coming in at over $5m for its company, Pfizer Inc. Lipitor is the brand name for an atorvastatin calcium medication that is pres...

The Asymptomatic Patient With Abnormal Laboratory Test Results

MatBA - Mature B-cell neoplasm array

Mature B-cell neoplasms arise in B-cells that have entered germinal centers within lymph nodes as part of the immune response. They display great heterogeneity at the clinical, pathologic, and genet...

Nexium

Nexium is the 2nd most profitable drug in 2009, according to 2009 annual sales figures, where it generated just over $5m in sales for its company, AstraZeneca Pharmaceuticals.  Nexium is a pr...

Matching News

LFB: M&A activity 2009 – 2014

LFB has announced only one M&A deal since 2009, with the acquisition of GTC TherapeuticsAbstracted from: Report: Partnering Agreements with LFB 2009-2014 LFB Group is not an active acquirer. In th...

Private Label Nutraceuticals Honored by Inc. 5000 as One of Today’s Fastest Growing Private Companies in America with Three-Year Sales Growth of 620%

Atlanta, GA (PRWEB) August 27, 2014 Private Label Nutraceuticals, prominent contract manufacturer of custom labeled nutritional dietary supplements and products has been recognized by Inc. magazi...

Proposed CMS Rule Increases OIG and FCA Focus on Fraud on the Medicare Part D Prescription Drug Benefit

Ross Brooks and Inayat Ali Hemani | Sanford Heisler LLP The Medicare Part D Prescription Drug Benefit (“Part D”) has dramatically increased the role of private government contractors in the d...

China Government Takes Steps To Encourage Private Health-Care Services

China's government has rolled out a plan intended to encourage establishment of more private health facilities, fostered in part by a relaxation of price controls.

Medivation: Biopharmaceutical partnering activity 2009 -2014

Medivation, a top big biotech company headquartered in the USA, is focused on development of therapies to treat serious diseases. This article throws light on the partnering activity of this successfu...

Biomarin: Partnering activity 2009-2014

Biomarin, a top big biotech company, focusses on developing and commercializing innovative biopharmaceuticals for serious diseases and medical conditions. The company’s partnering activity is review...

Amgen regains denosumab rights from GSK

Amgen Inc. (NASDAQ:AMGN) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) mutually agreed to end part of a 2009 deal under which GSK had rights to co-commercialize Amgen's Prolia denosumab for postmenopaus...

China urges more private capital in health insurance sector

SHANGHAI, Aug 28 (Reuters) - China will encourage more private investment in health insurance, part of Beijing's push to open up its overburdened healthcare sector, the official Xinhua news agency sai...

Matching PubMed Articles

Teaching Basic Life Support to Students of Public and Private High Schools.

Background: Despite being recommended as a compulsory part of the school curriculum, the teaching of basic life support (BLS) has yet to be implemented in high schools in most countries. Objectives: T...

Private Practice of Prosthodontists in the United States: Results from the 2008 & 2011 Surveys of Prosthodontists.

The purpose of this article is to review data and results from past surveys of prosthodontists sponsored and conducted by the American College of Prosthodontists. Surveys were conducted in 2002, 2005,...

Socioeconomic Disparities in Diagnostic Testing after Positive Aneuploidy Screening.

Objective The objective of this study was to investigate the association between type of health insurance (Medicaid vs. private) and uptake of diagnostic testing for fetal aneuploidy after a positiv...

Reflections on public-private participation in healthcare.

Health care is one of the major issues in social policy, affected by multiple factors, such as the increase in health costs, crisis, and the degree of private participation in the financing of service...

The dynamics of the morbidity rate of stroke in the Dagestan Republic.

Results of the first epidemiologic survey of cerebral stroke in the Dagestan Republic (DR) carried out in 2009-2010 are presented. Using a population register, we evaluated the dynamics of the morbidi...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement